For the readers interested in the stock health of TC Biopharm (Holdings) Plc (TCBP). It is currently valued at $3.69. When the transactions were called off in the previous session, Stock hit the highs of $4.0914, after setting-off with the price of $3.21. Company’s stock value dipped to $3.155 during the trading on the day. When the trading was stopped its value was $3.06.Recently in News on March 7, 2023, TC BioPharm Shifts Focus to FDA Clinical Trials. Company to explore US IND pathway for additional combination trials. You can read further details here
TC Biopharm (Holdings) Plc had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $106.50 on 03/29/22, with the lowest value was $2.81 for the same time period, recorded on 12/28/22.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
TC Biopharm (Holdings) Plc (TCBP) full year performance was -91.80%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, TC Biopharm (Holdings) Plc shares are logging -96.54% during the 52-week period from high price, and 31.32% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.81 and $106.50.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 779071 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the TC Biopharm (Holdings) Plc (TCBP) recorded performance in the market was -4.16%, having the revenues showcasing -17.08% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 3.36M, as it employees total of 76 workers.
Analysts verdict on TC Biopharm (Holdings) Plc (TCBP)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 5.64, with a change in the price was noted -7.04. In a similar fashion, TC Biopharm (Holdings) Plc posted a movement of -65.61% for the period of last 100 days, recording 734,998 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TCBP is recording 3.33 at the time of this writing. In addition, long term Debt to Equity ratio is set at 1.92.
TC Biopharm (Holdings) Plc (TCBP): Technical Analysis
Raw Stochastic average of TC Biopharm (Holdings) Plc in the period of last 50 days is set at 11.64%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 16.05%. In the last 20 days, the company’s Stochastic %K was 7.68% and its Stochastic %D was recorded 4.34%.
Let’s take a glance in the erstwhile performances of TC Biopharm (Holdings) Plc, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -4.16%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -78.36%, alongside a downfall of -91.80% for the period of the last 12 months. The shares increased approximately by 1.10% in the 7-day charts and went up by -40.77% in the period of the last 30 days. Common stock shares were lifted by -17.08% during last recorded quarter.